We are live on ! Find out more
ADMA icon

ADMA Biologics
ADMA

90 hedge funds and large institutions have $67.7M invested in ADMA Biologics in 2021 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 20 increasing their positions, 35 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

6.57% less ownership

Funds ownership: 40.03% → 33.46% (-6.6%)

14% less funds holding

Funds holding: 105 → 90 (-15)

21% less capital invested

Capital invested by funds: $85.4M → $67.7M (-$17.7M)

43% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 35

47% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 32

80% less call options, than puts

Call options by funds: $712K | Put options by funds: $3.49M

Holders
90
Holders Change
-15
Holders Change %
-14.29%
% of All Funds
1.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
20
Reduced
35
Closed
32
Calls
$712K
Puts
$3.49M
Net Calls
-$2.77M
Net Calls Change
-$513K

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$2.57M
2
Millennium Management
Millennium Management
New York
+$1.76M
3
CC
Clearline Capital
New York
+$1.01M
4
GCP
GSA Capital Partners
United Kingdom
+$548K
5
E
Ergoteles
New York
+$527K

Top Sellers

1
BlackRock
BlackRock
New York
-$6.29M
2
N
Nuveen
North Carolina
-$1.5M
3
MS
Maven Securities
Jersey
-$1.32M
4
State Street
State Street
Massachusetts
-$1.05M
5
Northern Trust
Northern Trust
Illinois
-$874K
Name Holding Trade Value Shares
Change 		Change in
Stake
PAM
76
Panagora Asset Management
Massachusetts
$2K -$222 -126 -11%
MAM
77
Meeder Asset Management
Ohio
$2K – – –
CAPTRUST Financial Advisors
78
CAPTRUST Financial Advisors
North Carolina
$2K +$1.91K +1,084 New
PNC Financial Services Group
79
PNC Financial Services Group
Pennsylvania
$2K +$2.81K +1,600 New
New York State Common Retirement Fund
80
New York State Common Retirement Fund
New York
$1K -$70.4K -40,022 -99%
TRCT
81
Tower Research Capital (TRC)
New York
$1K -$44.7K -25,387 -98%
HWMA
82
Heritage Wealth Management (Arizona)
Arizona
$1K +$176 +100 New
CFFP
83
Center for Financial Planning
Michigan
$1K +$669 +380 New
ASN
84
Advisory Services Network
Georgia
$1K +$880 +500 New
GWMIA
85
Global Wealth Management Investment Advisory
Florida
$1K +$880 +500 New
MF
86
Magnetar Financial
Illinois
$970 -$20.7K -11,791 -2%
MS
87
Maven Securities
Jersey
– -$1.32M -750,325 Closed
Franklin Resources
88
Franklin Resources
California
– -$775K -440,201 Closed
Alyeska Investment Group
89
Alyeska Investment Group
Illinois
– -$468K -265,820 Closed
California Public Employees Retirement System
90
California Public Employees Retirement System
California
– -$280K -159,100 Closed
PCM
91
Peregrine Capital Management
Minnesota
– -$214K -121,657 Closed
California State Teachers Retirement System (CalSTRS)
92
California State Teachers Retirement System (CalSTRS)
California
– -$175K -99,682 Closed
ECM
93
ExodusPoint Capital Management
New York
– -$163K -92,360 Closed
AllianceBernstein
94
AllianceBernstein
Tennessee
– -$144K -82,000 Closed
RhumbLine Advisers
95
RhumbLine Advisers
Massachusetts
– -$114K -64,698 Closed
AIG
96
American International Group
New York
– -$68 -38,412 Closed
AC
97
Apogem Capital
New York
– -$67K -38,346 Closed
Thrivent Financial for Lutherans
98
Thrivent Financial for Lutherans
Minnesota
– -$66K -37,525 Closed
EGM
99
Engineers Gate Manager
New York
– -$60K -34,170 Closed
DTL
100
Dynamic Technology Lab
Singapore
– -$56K -31,982 Closed
1 2 3
4
5

ADMA Hedge Fund Activity: Q2 2021 in Review

90 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in ADMA Biologics (ADMA) for Q2 2021, worth a combined $67.7M — down 21% from $85.4M a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of ADMA and 17 opened new positions — a net loss of 15 holders — while 35 trimmed existing stakes and 20 added.

The largest buyer was Vanguard Group, adding an estimated $2.57M. The largest seller was BlackRock, cutting an estimated $6.29M.

  • 90 institutional investors held ADMA Biologics (ADMA) as of Q2 2021, down from 105 in Q1 2021.
  • Funds reported $67.7M of ADMA Biologics stock for Q2 2021, down 21% quarter-over-quarter.
  • 17 funds opened new ADMA Biologics positions in Q2 2021 and 32 closed out, a net change of -15 holders.
  • The largest ADMA Biologics buyer in Q2 2021 was Vanguard Group, an estimated $2.57M added.
  • The largest ADMA Biologics seller in Q2 2021 was BlackRock, an estimated $6.29M sold.

Based on aggregated 13F filings for Q2 2021.